Cargando…

Is radical local therapy effective in postoperative recurrent EGFR ‐mutated non‐small cell lung cancer?

BACKGROUND: Long‐term survival can be achieved with radical local therapy in some cases of postoperative recurrence of non‐small cell lung cancer (NSCLC). Here, we evaluated post‐recurrence survival (PRS) after treatment of postoperative recurrent epidermal growth factor receptor (EGFR) mutated NSCL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takenaka, Tomoyoshi, Yano, Tokujiro, Yamazaki, Koji, Okamoto, Tatsuro, Hamatake, Motoharu, Takamori, Shinkichi, Kohno, Mikihiro, Miura, Naoko, Shimokawa, Mototsugu, Yoshizumi, Tomoharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290912/ https://www.ncbi.nlm.nih.gov/pubmed/37143400 http://dx.doi.org/10.1111/1759-7714.14911

Ejemplares similares

Survival after recurrence following surgical resected non-small cell lung cancer: A multicenter, prospective cohort study
por: Takenaka, Tomoyoshi, et al.
Publicado: (2022)

Association between sex and outcomes in patients with non-small-cell lung cancer receiving combination chemoimmunotherapy as a first-line therapy: a systematic review and meta-analysis of randomized clinical trials
por: Takada, Kazuki, et al.
Publicado: (2022)

Conservative treatment for residual lung congestion after left upper trisegmentectomy: a case report
por: Nagano, Taichi, et al.
Publicado: (2023)

The clinical impact of concomitant medication use on the outcome of postoperative recurrent non-small-cell lung cancer in patients receiving immune checkpoint inhibitors
por: Takada, Kazuki, et al.
Publicado: (2022)

Prognostic impact of noninvasive areas in resected pathological stage IA lung adenocarcinoma
por: Kinoshita, Fumihiko, et al.
Publicado: (2023)

Skeletal muscle area predicts the outcomes of non-small-cell lung cancer after trimodality therapy
por: Watanabe, Kenji, et al.
Publicado: (2023)

A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study
por: Takada, Kazuki, et al.
Publicado: (2022)

Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)
por: Takada, Kazuki, et al.
Publicado: (2021)

Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”
por: Takada, Kazuki, et al.
Publicado: (2021)

Chronological analysis of the gut microbiome for efficacy of atezolizumab‐based immunotherapy in non‐small cell lung cancer: Protocol for a multicenter prospective observational study
por: Shoji, Fumihiro, et al.
Publicado: (2022)

Relationship between consolidation tumor ratio and tumor‐infiltrating lymphocytes in small‐sized lung adenocarcinoma
por: Ono, Yuki, et al.
Publicado: (2022)

Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma
por: Hashinokuchi, Asato, et al.
Publicado: (2022)

Multiple systemic artery to pulmonary vessel fistulas (SAPVFs) completely resected by video-assisted thoracoscopic surgery: a case report
por: Matsudo, Kyoto, et al.
Publicado: (2022)

Mediastinal synovial sarcoma invading the right inferior pulmonary vein and left atrium
por: Nagano, Taichi, et al.
Publicado: (2023)

Combination Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients with NSCLC Receiving Carboplatin-Based Chemotherapy
por: Shimokawa, Mototsugu, et al.
Publicado: (2022)

Prognostic impact of chronological age on efficacy of immune checkpoint inhibitors in non‐small‐cell lung cancer: Real‐world data from 86 173 patients
por: Takamori, Shinkichi, et al.
Publicado: (2021)

Impact of Liver Metastasis on First-Line Immunotherapy in Stage IV Non-Small Cell Lung Cancer
por: Komiya, Takefumi, et al.
Publicado: (2023)

Impact of the pretreatment prognostic nutritional index on the survival after first‐line immunotherapy in non‐small‐cell lung cancer patients
por: Oku, Yuka, et al.
Publicado: (2023)

Surgical resection of a tuberculoma in the diaphragm: a case report
por: Hashinokuchi, Asato, et al.
Publicado: (2022)

Gut microbiota diversity and specific composition during immunotherapy in responders with non-small cell lung cancer
por: Shoji, Fumihiro, et al.
Publicado: (2022)

The impact of immune-inflammation-nutritional parameters on the prognosis of non-small cell lung cancer patients treated with atezolizumab
por: Matsubara, Taichi, et al.
Publicado: (2020)

Prospective observational study of nutritional/immunologic indices as predictive biomarkers for the response to anti-PD-1 drugs in non-small cell lung cancer (ICI-PREDICT study)
por: Takamori, Shinkichi, et al.
Publicado: (2021)

Short progression‐free survival of ALK inhibitors sensitive to secondary mutations in ALK‐positive NSCLC patients
por: Haratake, Naoki, et al.
Publicado: (2019)

Case report: Success of tepotinib therapy in overcoming resistance to osimertinib in a patient with EGFR-mutant lung adenocarcinoma with a potential acquired MET exon 14 skipping mutation
por: Takamori, Shinkichi, et al.
Publicado: (2022)

Artificial intelligence-derived gut microbiome as a predictive biomarker for therapeutic response to immunotherapy in lung cancer: protocol for a multicentre, prospective, observational study
por: Shoji, Fumihiro, et al.
Publicado: (2022)

Long-term complete response to gefitinib after treatment termination in a patient with recurrent post-operative EGFR-mutated lung adenocarcinoma: case report and literature review
por: Watanabe, Kenji, et al.
Publicado: (2021)

The significant influence of having children on the postoperative prognosis of patients with nonsmall cell lung cancer: A propensity score‐matched analysis
por: Takamori, Shinkichi, et al.
Publicado: (2018)

Stage IV pleomorphic carcinoma of the lung without recurrence for 6 years: a case report
por: Miura, Naoko, et al.
Publicado: (2017)

Eliminating microscopic lymph node metastasis by performing pelvic lymph node dissection during radical prostatectomy for prostate cancer
por: Furubayashi, Nobuki, et al.
Publicado: (2020)

Assessment of pleural air leakage using digital chest drainage system after surgical pulmonary resection: Comparison of visible alveolar air leakage with the digital value measured by a digital chest drainage system
por: Mori, Ryo, et al.
Publicado: (2017)

Prognostic value of postoperative decrease in serum albumin on surgically resected early-stage non-small cell lung carcinoma: A multicenter retrospective study
por: Kinoshita, Fumihiko, et al.
Publicado: (2021)

Anti–PD-1 Monotherapy for Advanced NSCLC Patients with Older Age or Those with Poor Performance Status
por: Matsubara, Taichi, et al.
Publicado: (2021)

Dramatic intracranial response to tepotinib in a patient with lung adenocarcinoma harboring MET exon 14 skipping mutation
por: Takamori, Shinkichi, et al.
Publicado: (2021)

Successful treatment of locally advanced lung cancer using late concurrent chemoradiation therapy administered after immune checkpoint inhibitor plus platinum chemotherapy
por: Matsubara, Taichi, et al.
Publicado: (2021)

Cohesion between pulmonary artery and bronchus after immune checkpoint inhibitor therapy in a lung cancer patient
por: Takamori, Shinkichi, et al.
Publicado: (2020)

Clinical implications of the novel cytokine IL-38 expressed in lung adenocarcinoma: Possible association with PD-L1 expression
por: Takada, Kazuki, et al.
Publicado: (2017)

Clinical impact of number of lymph nodes dissected on postoperative survival in node-negative small cell lung cancer
por: Takamori, Shinkichi, et al.
Publicado: (2022)

Up‐regulated LRRN2 expression as a marker for graft quality in living donor liver transplantation
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

MicroRNA‐326 negatively regulates CD155 expression in lung adenocarcinoma
por: Nakanishi, Takayuki, et al.
Publicado: (2023)

Correspondence Regarding “Sleeve Lobectomy After Neoadjuvant Chemoimmunotherapy Versus Chemotherapy for Squamous Cell Lung Cancer: A Multicenter, Retrospective Study”
por: Takada, Kazuki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4s0sv49fit4s6sg13g4e9r74gh